Blog

Casting after Covid-19 or Premature Predictions about COFDI’s Demise

Last month, I wrote pessimistically about the prospects for foreign direct investment (FDI) in China in the post-coronavirus world.  Contrastingly, I am not so pessimistic about the future of Chinese outward FDI (OFDI), though China’s economic situation, the challenged cash flows and balance sheets of Chinese investors (state-owned and private),…

The New Online World Could Mean Offline for FDI in China: Political and Economic Factors Affecting Future FDI in China’s Online World

The coronavirus, otherwise known as Covid-19, has hit foreign direct investment (FDI) flows into China hard.  This should surprise no one—money is scarce; the payback from FDI now seems far away; and resources are being husbanded on the home front.  This has not stopped foreign businesspeople in China from trying…

De virus, Decoupling, De-globalization, Downsizing, and FDI in China

China’s coronavirus epidemic has had profound economic effects including dramatically reducing travel within and outside China, severely suppressing business activity in the education, entertainment, food & beverage, and leisure and recreation industries, among others, and disrupting or freezing manufacturing and the delivery of production inputs and end goods.  It is…

The Phase I Trade Deal and FDI, Part I-Financial Services

Previously, I expressed mild skepticism and then later guarded optimism about China’s financial sector opening. The recent United States-China Phase One trade deal suggests the situation may be even better than originally thought with one entire chapter of the agreement speaking to the sector’s opening.

Europe Facing Disconnection Disaster over Huawei and Curbs on Chinese Companies?

European countries like Germany, the United Kingdom, and Norway have been struggling over the extent to which they should use equipment and services and accept foreign direct investment (FDI) from Chinese telecommunication firms.  The United States has played no small role in fueling these actors’ quandaries by warning loudly and…

Getting High on China: The High Cost of Low-Priced Drugs for Pharma Firms?

Recently, foreign pharmaceutical makers such as AbbVie, AstraZeneca, Novartis, Sanofi, and Roche slashed the prices of a large number of drugs sold in China, the world’s second largest drug market.  They cut prices far below their prices in the United States (US) and elsewhere so Beijing would put these drugs…

No Promise Left Behind: The Effort to Court EU FDI through a China-EU BIT

China and the European Union (EU) have been discussing a bilateral investment treaty (BIT) for a long time.  Indeed, the two sides held their 21st round of China-EU BIT negotiations in June 2019.  This round seemed odd given that just 1 year before Chinese media and connected interviewees were touting…

Pundits Posit China’s New Foreign Direct Investment Law Progresses!

In May, China passed a new law relating to Foreign Direct Investment (FDI) that comes into effect at the beginning of 2020.  This law replaces three laws relating to wholly-owned foreign enterprises, contractual joint ventures (JVs), and equity JVs that previously constituted China’s formal FDI regime.  Many were encouraged by…

Investing in No Chinese Investment

These days “Washington” seems to think little of Chinese investment.  It does not matter if it is Chinese foreign direct investment (FDI) in the United States (US) or US FDI in China.  Importantly, the core concerns in each case are different.  The former largely has been a security issue because…

The Free Trade Zone that Ate Shanghai

The Shanghai Free Trade Zone (SFTZ) came into being in 2013.  Since its birth, it has scored accomplishments such as faster customs processing times and easier business establishment.  Overall, however, it has disappointed, failing to deliver notable breakthroughs with respect to its negative list, free currency flows, or financial sector…